Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas W Morrell

Showing results (191-200 of 278) with videos related to

Pageof 28
Sort By:
The American Journal of Pathology|January 1, 2009
Activin-like kinase 5 (ALK5) mediates abnormal proliferation of vascular smooth muscle cells from patients with familial pulmonary arterial hypertension and is involved in the progression of experimental pulmonary arterial hypertension induced by monocrotalineMatthew Thomas, Cerys Docx, Alan M Holmes, et al.
Chest|January 22, 2022
Different Cytokine Patterns in BMPR2-Mutation-Positive Patients and Patients With Pulmonary Arterial Hypertension Without Mutations and Their Influence on SurvivalMax Schwiening, Emilia M Swietlik, Divya Pandya, et al.
American Journal of Respiratory and Critical Care Medicine|November 3, 2017
Loss of SMAD3 Promotes Vascular Remodeling in Pulmonary Arterial Hypertension via MRTF DisinhibitionDiana Zabini, Elise Granton, Yijie Hu, et al.
Circulation|February 1, 2017
Elabela/Toddler Is an Endogenous Agonist of the Apelin APJ Receptor in the Adult Cardiovascular System, and Exogenous Administration of the Peptide Compensates for the Downregulation of Its Expression in Pulmonary Arterial HypertensionPeiran Yang, Cai Read, Rhoda E Kuc, et al.
Circulation|August 18, 2010
Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertensionElaine Soon, Alan M Holmes, Carmen M Treacy, et al.
The Journal of Clinical Investigation|May 24, 2016
MicroRNA-140-5p and SMURF1 regulate pulmonary arterial hypertensionAlexander M K Rothman, Nadine D Arnold, Josephine A Pickworth, et al.
Molecular and Cellular Biology|September 14, 2017
Correction for Bagarova et al., "Constitutively Active ALK2 Receptor Mutants Require Type II Receptor Cooperation"Jana Bagarova, Ashley J Vonner, Kelli A Armstrong, et al.
Molecular and Cellular Biology|April 11, 2013
Constitutively active ALK2 receptor mutants require type II receptor cooperationJana Bagarova, Ashley J Vonner, Kelli A Armstrong, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 30, 2010
Dynamic changes in lung microRNA profiles during the development of pulmonary hypertension due to chronic hypoxia and monocrotalinePaola Caruso, Margaret R MacLean, Raya Khanin, et al.
Pulmonary Circulation|September 10, 2013
Circulating angiogenic modulatory factors predict survival and functional class in pulmonary arterial hypertensionRajeev Malhotra, Samuel Paskin-Flerlage, Roham T Zamanian, et al.
Pageof 28

Showing results (191-200 of 278) with videos related to

Sort By:
Pageof 28
The American Journal of Pathology|January 1, 2009
Activin-like kinase 5 (ALK5) mediates abnormal proliferation of vascular smooth muscle cells from patients with familial pulmonary arterial hypertension and is involved in the progression of experimental pulmonary arterial hypertension induced by monocrotalineMatthew Thomas, Cerys Docx, Alan M Holmes, et al.
Chest|January 22, 2022
Different Cytokine Patterns in BMPR2-Mutation-Positive Patients and Patients With Pulmonary Arterial Hypertension Without Mutations and Their Influence on SurvivalMax Schwiening, Emilia M Swietlik, Divya Pandya, et al.
American Journal of Respiratory and Critical Care Medicine|November 3, 2017
Loss of SMAD3 Promotes Vascular Remodeling in Pulmonary Arterial Hypertension via MRTF DisinhibitionDiana Zabini, Elise Granton, Yijie Hu, et al.
Circulation|February 1, 2017
Elabela/Toddler Is an Endogenous Agonist of the Apelin APJ Receptor in the Adult Cardiovascular System, and Exogenous Administration of the Peptide Compensates for the Downregulation of Its Expression in Pulmonary Arterial HypertensionPeiran Yang, Cai Read, Rhoda E Kuc, et al.
Circulation|August 18, 2010
Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertensionElaine Soon, Alan M Holmes, Carmen M Treacy, et al.
The Journal of Clinical Investigation|May 24, 2016
MicroRNA-140-5p and SMURF1 regulate pulmonary arterial hypertensionAlexander M K Rothman, Nadine D Arnold, Josephine A Pickworth, et al.
Molecular and Cellular Biology|September 14, 2017
Correction for Bagarova et al., "Constitutively Active ALK2 Receptor Mutants Require Type II Receptor Cooperation"Jana Bagarova, Ashley J Vonner, Kelli A Armstrong, et al.
Molecular and Cellular Biology|April 11, 2013
Constitutively active ALK2 receptor mutants require type II receptor cooperationJana Bagarova, Ashley J Vonner, Kelli A Armstrong, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 30, 2010
Dynamic changes in lung microRNA profiles during the development of pulmonary hypertension due to chronic hypoxia and monocrotalinePaola Caruso, Margaret R MacLean, Raya Khanin, et al.
Pulmonary Circulation|September 10, 2013
Circulating angiogenic modulatory factors predict survival and functional class in pulmonary arterial hypertensionRajeev Malhotra, Samuel Paskin-Flerlage, Roham T Zamanian, et al.
Pageof 28